Hepatic changes in different hormone replacement therapies in climacteric

Measurements of liver enzymes (ASAT, ALAT, GGT, AP) and SHBG were carried out in 128 postmenopausal women during 12 months of different hormone replacement therapies. There was no negative effect on these liver enzymes. ASAT, ALAT, GGT and AP decreased during the 12 months of treatment. Transdermal...

Full description

Saved in:

Bibliographic Details
Published in:	Zentralblatt für Gynäkologie Vol. 117; no. 7; p. 349
Main Authors:	Foth, D, Römer, T, Panzig, E
Format:	Journal Article
Language:	German
Published:	Germany 1995
Subjects:	Administration, Cutaneous Administration, Oral Climacteric - drug effects Drug Therapy, Combination Enzymes - blood Estrogen Replacement Therapy - adverse effects Estrogen Replacement Therapy - methods Female Humans Liver - drug effects Liver Function Tests Middle Aged Progesterone Congeners - administration & dosage Progesterone Congeners - adverse effects Prospective Studies
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Measurements of liver enzymes (ASAT, ALAT, GGT, AP) and SHBG were carried out in 128 postmenopausal women during 12 months of different hormone replacement therapies. There was no negative effect on these liver enzymes. ASAT, ALAT, GGT and AP decreased during the 12 months of treatment. Transdermal replacement therapy did not induce a higher level of SHBG.
ISSN:	0044-4197